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In a previous publication, the author (1) has set forth the results of 
a study of the agglutination  reactions of twenty-five strains of Strep- 
tococcus  h~molyticus  isolated from  the throats  of  patients  suffering 
from  scarlet  fever.  Of  these  strains,  twenty  were  agglutinated  at 
equal taters by four separate immune sera prepared by the immuniza- 
tion of rabbits to individual strains of scarlatinal streptococci.  With 
the exception of four strains,  none was agglutinated  by any of four 
antistreptococcic sera obtained by immunization  of animals to strains 
of Streptococcus  hemolyticus isolated from diseases other  than  scarlet 
fever.  These-facts suggest that  certain hemolytic streptococci found 
in the  throats  of scarlet fever tmtients  constitute  a  single biological 
group. 
The simultaneous studies of Tunnicliff (2) reveal a similar relationship between 
strains of Streptococcus hcemolyticus associated with scarlet fever.  More recently, 
Gordon (3) has found  that eighteen strains  of hemolytic streptococcus isolated 
from  scarlatina  are  identical  in  their  agglutination reactions.  None of these 
strains  absorbed the agglutinins from immune sera prepared  from certain  other 
types of hemolytic streptococcus, designated by him as Types I and II.  On the 
basis of this  evidence, Gordon concludes that the streptococci from the throat 
secretions in scarlet  fever constitute  a  group  serologicaily distinct  from  other 
varieties of Streptococcus pyogenes. 
The occurrence of hemolytic streptococcus in the throats of patients 
with scarlet fever is well known and it seems unnecessary to review the 
literature  on the subject at the present time.  The most recent ob- 
servations indicate that Streptococcus  hcemolylicus is almost constantly 
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associated with this disease.  In the author's series of cases hemolytic 
streptococcus has been obtained from the throats of 100 per cent of all 
patients cultured during the 1st week of illness.  In those individuals 
from whom cultures were taken during the first few days of the disease 
the above organism was found to predominate on the plates.  After 
the  1st  week of the disease the  number of hemolytic streptococci 
diminishes rapidly, although great numbers may still be present as 
late as the 12th day.  The average length of time that these organisms 
are carried in the throat secretions is  10 days.  Several examples of 
the carrier condition have been encountered, and in one individual 
the specific  streptococcus was  found to  be  present in  considerable 
numbers in the throat 1 year after the attack of scarlet fever. 
No morphological or cultural characteristics that seem to differen- 
tiate the hemolytic  streptococcus associated with scarlatina from other 
types  of  Streptococcus pyogenes have  been  demonstrated.  Many 
observers have emphasized the variability of the scarlet fever strepto- 
cocci, and because of this have regarded them as secondary invaders. 
Such variations as occur seem in all likelihood to be related to incon- 
stancy  of  the  cultural  environment  rather  than  to  fundamental 
biological differences.  The more recent studies of  this organism in- 
dicate that differences of this  character are of very little value in 
dividing the group into its specific varieties. 
The  organisms which have been  examined in the present series 
have been characterized on isolation by  wide variations in growth 
characters. 
Some have been very minute and others relatively large.  Some grow in short 
chains, others in long ones.  A curious tendency to loss of Gram positiveness has 
been observed.  Although the organisms originally obtained from  the peritoneal 
exudates of mice or from blood agar plates retain the Gram stain, the same strains 
in transplants from old stock cultures or after cultivation in broth may be con- 
tinuously  Gram-negative.  Certain  strains  manifest  a  tendency  to  develop  so 
called involution forms on cultivation in broth media.  Many of the individual 
cocci become  from  two  to  three  times  their original size and  appear  swollen. 
Sometimes a  culture will become almost entirely converted into forms  of  this 
character.  Cultivation of such strains in enriched media or even animal passage 
fails  to  restore the normal morphology.  Coincident with this change in size the 
strain may become inagglutinable in an immune serum which previously agglu- 
tinated it in high titer.  One strain (SH26)  exhibited this irregular morphology WALTER  PARKS  BLISS  577 
from the time of isolation and was continuously inagglutinable.  The appearance 
of the colony on blood agar plates is fairly constant, a small moist slightly raised 
colony with a smooth margin, appearing through a hand lens as an evenly, finely 
granular  dewdrop.  About  the  colony  there  is  a  zone  of  complete hemolysis, 
of about the same width as the diameter of the colony.  The extent of hemolysis, 
however, varies with different conditions of the media.  In some instances the 
colonies are extremely minute with wide coalescing areas of hemolysis, and in 
others the zone of hemolysis is quite narrow--from one-half to one-third of the 
diameter of the colony.  Subsequent cultivations indicate that these differences 
are not constant and that they are dependent upon slight unexplained variations 
in media or in growth activity. 
The hemolytic streptococci from scarlet fever show  the  saxae  ten- 
dency to granular growth in broth  that  is such a  constant  feature  of 
other  types  of Streptococcus h¢emolyticus.  Great variations, however, 
in this characteristic are observed. 
All strains when first isolated tend to flocculate when cultivated in broth or when 
exposed for  a  few hours in the water bath  to  a  temperature of 55°C.  Most 
strains will grow diffusely in broth after repeated transfers in this medium.  Some 
require relatively few transfers and others from twenty to thirty passages before 
stable suspensions can be obtained.  Certain strains remain persistently granular 
even after daily passage in broth media for long periods of time.  Occasionally a 
strain will grow diffusely for a  while and then again become granular although 
there has been no recognizable change in the character of the culture medium or in 
the method of handling the organism.  Once an organism acquires the character of 
diffuse growth sufficiently stable suspensions can usually be prepared to carry out 
the agglutination reaction at 55°C. 
Certain qualities of the medium  promote  diffuseness of growth. 
The addition of glucose or of ascitic fluid causes the cultures to grow luxuriantly 
and diffusely at incubator temperature, but when such organisms are exposed to 
normal serum, in the water bath at 55°C., they tend to flocculate, obscuring the 
results of the  agglutination tests.  It  has  been found  that  flocculation occurs 
when the sugar concentration is above 0.2 per cent, and that when the concentra- 
tion is below 0.1 per cent the organisms fai[ to grow sufficiently to give a  satis- 
factory suspension.  Slight variations in the sodium chloride or protein content of 
broth have no demonstrable effect on the luxuriance or diffuseness of growth.  In 
broth made of meat extract the organisms grow poorly or flocculate, and  any 
appreciable variation from a final hydrogen ion concentration of the medium after 
sterilization of pI-I 7.5  results in insufficient growth or flocculation, or  usually 
both.  Certain difficulties have been traced to the use of tap water instead of 
distilled water in the preparation of the medium.  It has been found that  the 
addition of i or 2 drops of boiled tomato juice to a tube of broth (as used by Thj6tta 578  BIOLOGY  01  ~  s~rlLEPTOCOCCUS.  II 
and Avery (4)) facilitates the growth of the organisms, and does not interfere with 
agglutination.  Passage  of  autoagglutinable  strains  through  mice  sometimes 
renders  them  diffuse,  but  because  of  the  observations  of Aronson  (5),  Meyer 
(6),  and others,  that passage through  animals makes cultures less agglutinable, 
the strains used in the present experiments were not passed through animals but 
grown  continuously in broth. 
A great variety of fermentation reactions in carbohydrate broth of 
hemolytic streptococci isolated from the throats of scarlet fever pa- 
tients has been recorded by different workers.  This has led many to 
believe that they were dealing not with a single  type but with a great 
number of varieties of Streptococcus hvemolyticus. 
It is, of course, a  question how much significance should be attached  to these 
differences in reaction to sugars, particularly in view of the lack of uniformity  of 
the methods employed.  Using for convenience the nomenclature of Holman (7) 
in his classification of streptococci on a basis of carbohydrate fermentation reac- 
tions,  and  considering  only strains  of hemolytic streptococci  isolated from the 
throats of scarlet fever patients, we find, for example, that Ruediger (8) in a study 
of  thirty-seven  such  strains,  groups  some  as  Streptococcus infrequens  (lactose, 
salicin,  mannitol  fermenters),  and  others  as  Str*ptococcus pyogenes  (lactose, 
salicin,  non-mannitol  fermenters);  Kligler  (9)  encountered  Streptococcus  in- 
frequens  and  Andrewes  and  Horder  (10)  found  ten  strains  of  Streptococcus 
anginosus  (lactose,  non-salicin,  non-mannitol  fermenters)  and  three  of Strepto- 
coccus  subacidus  (non-lactose,  non-saUcin,  non-mannitol  fermenters).  Floyd 
and  Wolbach  (11)  report  eleven  strains  of Streptococcus anginosus  and  five of 
Streptococcus subacidus.  Similar results have been reported by other investigators. 
Tunnicliff's  (2)  strains were with few exceptions Streptococcus pyogenes.  These 
rough  classifications  do  not  take into  account  many differences in  reaction  to 
saccharose, raifinose, and other less commonly used sugars. 
EXPERIMENTAL. 
Carbohydrate Fermentation. 
The carbohydrate fermentation reactions of the present series of 
throat strains are presented in Table I. 
It is seen that of 64 throat strains examined, 53 (82.8 per cent) are 
true Streplococcus pyogenes (Holman),  and if one accepts the opinion 
of  Gordon and others that certain strains  of pyogenes occasionally 
ferment  mannitol, one may be justified in assuming that six additional 
strains, or 59 in all (92 per cent), are Streptococcus pyogenes.  Of the TABLE  I. 
Carbohydrate Fermentation  by Strains  of Hemolytic  Streptococci Isolated from  the 
• Throats  of Scarlet Fever Patients. 
Strain  Lac-  i  Salicln.  Man-  Inulin.  Rafli-  Strain  Lac-  [  Salici  a.  Man-  Inulin.  Rafll- 
No.  tose.  nitol,  nose.  No.  tose.  '  nitol,  nose. 
n  +  +  -  -  -  74  +  +  -  -  - 
12  +  +  -  -  -  75  +  +  -  -  - 
13  +  +  -  -  -  76  +(?)  +  -  -  - 
14  +  +  --  --  --  77  +  +  -  -  - 
15  +  +  +  -  -  78  +  +  --  --  -- 
16  +  +  --  --  -  79  +  +  --  --  -- 
20  +  +  --  -  -  80  +  +  --  --  -- 
23  4-  +  --  --  --  81  4-  4-  --  --  -- 
24  +  +  --  --  --  82  +  +  --  --  -- 
25  +  +  +  --  --  83  +  +  --  --  -- 
26  +  +  --  --  --  84  +  +  --  --  -- 
27  +  +  --  --  --  88  +  +  --  --  -- 
28  +  +  +  --  --  89  +  +  --  --  + 
29  +  +  +  --  --  90  +  +  --  --  -- 
30  +  +  --  --  --  91  +  +  --  --  -- 
35  +  +  +  --  --  93  +  +  --  --  -- 
36  --  +  -  -  -  94  +  +  --  --  - 
38  +  +  -  -  -  95  +  +  -  -  - 
39  +  +  --  -  --  98  +  +  +  --  - 
45  +  +  --  --  +  99  +  +  --  --  -- 
47  +  +  - 
50  +  +  - 
53  +  +  -- 
54  +  +  - 
56  +  +  -- 
62  +  4-  -- 
65  +  +  -- 
66  +  +  -- 
67  4-  +  -- 
68  +  +  -- 
69  +  +  -- 
70  +  +  -- 
72  +  4-  -- 
73  +  +  -- 
m 
m 
m 
m 
m 
m 
201  4-  4-  -  -  - 
2o3  +  +  +  -  + 
205  +  +  -  -  - 
207  +  +  -  -  - 
-  208  +  + 
+  2O9  +  + 
-  2i0  +  + 
-  211  4-  + 
m 
m 
m 
212  +  4- 
213  +  + 
m  m  m 
N  m 
m  m 
m  m  m 
0.1  per  cent  carbohydrate  meat  infusion  broth  was  used  containing  Andrade 
indicator.  Incubated  1  week;  readings  made  daily. 
-[-  indicates  fermentation,  -  no  fermentation. 
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remaining five strains, four ferment raffinose, which puts them in the 
group of Streptococcus salivarius, presumably a  saprophytic type.  It 
is interesting to note in this connection that, as shown below, three of 
these raflinose-fermenting strains differ in their reactions to agglutinat- 
ing sere from the other strains.  In brief, it may be concluded from 
these results that most of the strains belong to the type of Streptococcus 
pyogenes, and do not differ in their carbohydrate fermentation reac- 
tions from strains isolated from acute tonsillitis, pharyngitis, erysipelas, 
and certain septic processes.  On the other hand, our experience does 
not demonstrate  the  existence  of  a  great  variety  of  carbohydrate- 
fermenting types.  Some strains  are slow fermenters, and it may be 
that some of the variations previously reported are due to incomplete 
observations.  Studies with the less common sugars have not been 
made. 
Agglutination  Tests. 
Numerous  investigators have  studied  the  agglutination reactions 
of streptococci.  The results on the whole have been rather conflict- 
ing due largely no doubt to differences of method and inherent techni- 
cal difficulties. 
Moser (12) and Moser and von Pirquet (13) have prepared polyvalent  sere from 
horses, using the streptococcus  of scarlet  fever  as antigen.  They studied the 
capacity of such sere  to  agglutinate specifically various strains of scarlatinal 
streptococci.  The  latter  strains were  agglutinated in  dilutions  of  1:1,000 or 
over,  whereas  hemolytic streptococci  from other  sources were  not specifically 
agglutinated.  As a consequence of these observations  the authors believe  that 
the streptococcus  of scarlet  fever  differs from similar  strains isolated from in- 
stances  of erysipelas;  phlegmon,  puerperal  sepsis,  etc:  Meyer  (6)  and  later 
Rossiwall and Schick (14) have in general  confirmed the results of Moser  and 
yon Pirquet. 
On the other hand, Hasenknopf and Salge (15), Aronson (5), and also Neufeld 
(16) have been unable to duplicate the above results.  They failed to  find defi- 
nitely specific relationships between the streptococci of scarlet fever and are of the 
opinion that it is not possible to differentiate between types of hemolytic  strepto- 
cocci by means of the agglutination reaction. 
The discordant results briefly reported  are no doubt  due in part 
to  technical  difficulties  encountered  in  the  effort to  study specific 
agglutinations of streptococcus and in part to the variety of methods WALTER  PARJ~S  BLISS  581 
employed.  The tendency of these organisms to agglutinate spontane- 
ously in  normal sera,  and in broth  and  saline  suspensions is  very 
confusing.  In addition,  animal passage and long continued growth 
in artificial media may induce variations in agglutinability.  More- 
over,  the methods of different investigators have not been strictly 
comparable.  For these reasons it has been impossible up to the pres- 
ent time to answer concluslvely the question as to whether or not the 
streptococci of scarlet fever form a specific immunologic type. 
In a  recent publication, Dochez, Avery, and Lancefield (17) have 
described a technique for the agglutination of streptococcus which has 
made it possible to differentiate between types of hemolytic strepto- 
cocci isolated from a variety of respiratory diseases.  Their procedure 
has been used in the present study.  Its essential points are the use for 
purposes of culture of a  meat  infusion broth  the reaction of which 
remains at or near pH 7.5.  No sodium chloride is added and in such 
medium most strains of streptococcus can be grown diffusely.  Broth 
of the same character and reaction is used in all the necessary dilutions 
both of organisms and of sera.  The test suspensions are incubated 
for 1½ hours in a water bath at 55°C. and then read. 
The  sera were prepared by inoculating  rabbits  intravenously at 
2 or 3 day intervals with increasing doses of heat-killed broth cultures, 
starting  with  0.2  cc.  and increasing to  2  cc.  All rabbit  sera  were 
tested before the first inoculation in order to guard against spontaneous 
agglutination by normal rabbit sera.  The above method  produced 
sera with a  titer of over 1:2,560.  It was noted that the serum im- 
mediately after separation from the clot showed an agglutinating titer 
markedly lower than after standing for 48 hours or longer in the ice 
chest, so only sera have been used which have remained at least 48 
hours on ice.  Such sera, however, lose their agglutinins after stand- 
ing for a few months. 
The results of the first series of agglutination tests have been re- 
ported (1).  They are recapitulated in Table II, with the addition of 
a few strains studied shortly thereafter. 
Table II shows that none of five non-scarlatinal antistreptococcic 
sera (R.Sm.3, t(.Sm.23,  1~.Sm.32,  R.Sm.60,  and K.Sm.84,  the  type 
sera of Dochez, Avery, and Lancefield) agglutinates any of the thirty- 
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of scarlet fever patients, with the exception of eight strains agglutinated 
by Serum R.Sm.84, and  Strain 63,  agglutinated by Serum  R.Sm.32. 
Each of the scarlatinal streptococcic sera used  agglutinates  twenty- 
eight out of thirty-four strains isolated from  patients  with  scarlet 
fever.  It is of some interest that of the six scarlet fever strains  not 
agglutinated by scarlatinal antisera, Strains 36, 45, and 62 differ from 
the  type  in  their  fermentation  reactions.  Strain  26  persistently 
showed large numbers of involution forms, a  phenomenon  character- 
istic of inagglutinable strains.  Strain 54, erroneously included in the 
series first  reported,  has  been  omitted  from  Table  II.  In  a  few 
instances individual agglutination tests have not been made because 
of deterioration of the sera during the summer months. 
In order to confirm the results reported in Table II an additional 
series of strains of streptococcus has been isolated from fresh cases of 
scarlet fever.  New sera have been prepared by the immunization of 
rabbits and  the specific agglutinating power of these sera has  been 
tested.  The results are summarized in Table III. 
Of the twenty-four new strains  studied,  twenty are agglutinated 
specifically by antiscarlatinal sera.  One strain (No. 79) displays some 
irregularity of agglutination, and three (Nos.  84,  203,  and  205)  fail 
completely to agglutinate.  If the statistics reported in Tables II and 
III are combined it is found that 80 per cent or more of  strains of 
streptococcus from scarlet fever are agglutinated by the specific sera 
employed.  In all, the various strains were tested with  ten different 
monovalent antistreptococcic sera.  On the other hand,  these same 
strains are not agglutinated by antistreptococcic sera prepared from 
hemolytic streptococci isolated from diseases or conditions other than 
scarlet  fever. 
A study of the capacity of immune sera prepared from the scarlati- 
hal streptococcus to agglutinate streptococci from a  variety of sources 
has also been made.  The results of this study are shown in Table 
IV. 
This table demonstrates that streptococci isolated from individuals 
not having scarlet fever or removed from contact with this disease do 
not agglutinate in antiscarlatinal sera.  Of the five strains showing 
agglutination (Nos. 112, D10, 10, 55, and 57), one (No. 112) was from 
a  chronic carrier, two (Nos. 10 and D10) were from recent contacts, WALTER  PARKS BLISS  585 
one (No. 55) from an infected mastoid shortly before the development 
by the patient of a typical scarlatinal rash followed by desquamation, 
and one (No. 57) from the throat of an individual suspected of having 
scarlet fever.  In general then it would seem that hemolytic strepto- 
cocci isolated from scarlet fever constitute a  specific type which can 
be separated by the reaction of agglutination  from hemolytic strep- 
tococci from other sources. 
A number of studies have previously been made of the power of the 
serum of convalescents from scarlet fever to agglutinate  the homolo- 
gous streptococcus.  The  results have been irregular and conflicting 
and are of no great .significance.  In spite of these apparent  failures 
to demonstrate a positive agglutination reaction the author has studied 
a few such sera.  The results are presented in Table V.  The degree 
of agglutination  obtained in a  few instances is considerable but the 
range  so  limited  that  positive  deductions  as  to  specificity  are 
unwarranted. 
Absorption of Agglutinin  Tests. 
Specific absorption of agglutinins  by streptococcus is a  procedure 
attended by certain  technical difficulties.  The high  temperature  at 
which the reaction must be carried out causes a  considerable loss of 
agglutinating  power by the immune sera employed.  The  use, how- 
ever, of a very heavy suspension of bacteria for purposes of absorption 
so shortens the period of incubation that no great deterioration occurs. 
The sediment of 50 cc. of a 24 hour broth culture of streptococcus was 
added to each cubic centimeter of a dilution of 1 : 5 of the serum to be 
absorbed.  The mixtures  were incubated  at 55°C.  for  2 hours with 
frequent shaking  and then the organisms were removed by centrifu- 
galization.  The  normal sera  used  as  controls  were  treated  for  a 
similar period of time.  The results are shown in Table VI. 
From this table it is seen that a scarlet fever streptococcus removes 
from an homologous serum  the  agglutinins  for the particular  strain 
used in its production and for other scarlet fever strains as well.  On 
the other hand,  a non-scarlafinal streptococcus does not absorb these 
agglutinins.  Furthermore,  a  scarlatinal  streptococcus  fails  to  ab- 
sorb  the  agglutinins  from  a  serum  prepared  by immunization  to  a 586  BIOLOGY  O]F  STREPTOCOCCUS.  II 
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o  ~ TABLE  V. 
Agglutination  of  Hemolytic  Streptococcus  from  the  Throats  of  Scarlet  Fever  Patients 
with  Scarlatinal  Convalescent  Sera. 
Scarlafinal 
strepto- 
coccus 
strains. 
12 
24 
25 
28 
11 
12 
14 
15 
23 
24 
25 
62 
11 
12 
14 
15 
24 
25 
R273 
11 
12 
14 
15 
24 
25 
R273 
80 
Convalescent  scarlafinal  sera. 
Dilution. 
1:8  [  1:16[ 1:32  ~:64 I.m 
Sm.62 (6th day).  --  --  --  -- 
"  62(6th  "  ).  --  .... 
"  62(6th  "  ).  --  .... 
"  62(6th  "  ).  --  --  ~  --  --  -- 
Sm.62 (18th day). 
"  62  (lSth  "  ). 
"  62 (18th  "  ). 
"  62 (18th  "  ). 
"  62 (18th  "  ). 
"  62 (18th  "  ). 
"  62 (18th  "  ). 
"  62 (18th  "  ) 
Sm.73 (4th day). 
"  73(4th  "  ). 
"  73(4th  "  ). 
"  73 (4th  "  ). 
"  73(4th  "  ). 
"  73(4th  "  ). 
"  73(4th  "  ). 
Sin.73  (18th day). 
"  73  (18th  "  ). 
"  73 (18th  "  ). 
"  73 (18th  "  ). 
"  73 (18th  "  ). 
"  73 (18th  "  ). 
"  73 (18th  "  ). 
81 
82 
94 
96 
112 
204 
206 
207 
201 
202 
204 
206 
Sm.203 (14th day). 
"  203  (14th  "  ). 
"  203  (14th  "  ). 
"  203  (14th  "  ). 
"  203  (14th  "  ). 
"  203  (14th  "  ). 
"  203  (14th  "  ). 
"  203 (14th  "  ). 
"  203  (14th  "  ). 
Sm.207 (15th day). 
"  207 (15th  "  ). 
"  207  (15th  "  ). 
"  207  (15th  "  ). 
++  +  -  _  _ 
++  +  +  -  _ 
+  +  -  _  _ 
++  ++  +  +  - 
++  +  +  -  _ 
+  +  -  _  _ 
++  ++  +  +  - 
++  ++  ++  ++  + 
! 
+  +i-  - 
+  +  -  _ 
++  ++  +  + 
+  +  i  +  +  ++  ++~  +  + 
++  +  +  - 
m 
m 
m 
++  +++  +++  +++  ++ 
1:256 
In  Tables  V  to  VIII,  XI,  XII,  and  XIV  -  indicates  no  agglutination, 
doubtful  agglutination,  +  slight  agglutination,  ++  frankly  positive  aggluti- 
nation,  +  ÷  q-  heavy  agglutination,  -b-b q- q-  complete agglutination. 
59O WALTER PARKS  BLISS  591 
streptococcus from a source other than scarlet fever.  Similar results 
are illustrated by Tables VII and VIII. 
The experiments shown in Tables VI to VIII show that it is possible 
to obtain a specific absorption of agglutinins from antiscarlatinal sera 
by use of streptococci from scarlet fever.  Success, however, did not 
attend all such efforts and from time to time insurmountable difficul- 
ties are encountered. 
Protection Tests. 
An effort has been made to confirm the specificity of the agglutina- 
tion reaction of the streptococci from scarlet fever by means of the 
protection test.  Antistreptococcic sera as a  rule have a  rather low 
protective value for experimental animals in comparison, for example, 
with antipneumococcic  sera.  Previous investigators who have studied 
this question have  reported in  some instances a  certain degree of 
specific protection and in others that the protective power of a mono- 
valent serumis manifest against more than one type of streptococcus. 
In carrying out this test it is important that the serum should have a 
fairly high protective titer and that the organisms used should be of 
maximum virulence in order that any single test may extend over a 
sufficiently wide  range  of  dosage.  In  the  experiments  shown  in 
Tables IX and X  the methods and conditions prescribed by Dochez, 
Avery, and Lancefield have been observed. 
These experiments show that it is possible to develop in immune 
sera a certain degree of protective value for white mice against highly 
virulent strains  of streptococcus isolated from  scarlet fever.  Such 
protective power is manifest not only against the homologous strain 
but also against strains from other cases of scarlet fever.  Immune 
sera prepared by the use of strains of hemolytic streptococcus from 
sources  other  than  scarlet  fever possess  no  such protective power 
against scarlatinal streptococci. 
Sludy of Contacts with Scarlet Fever. 
It has long been recognized that scarlet fever may be propagated 
by means of carriers and does not require direct contact for its trans- 
mission.  Sometimes the carrier may be a healthy individual, or may 
have suffered from a slight sore throat, without developing an exan- 592  BIOLOGY  0]~  STREPTOCOCCUS.  II 
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TABLE  IX. 
Protection  against  Virulent  Scarlatinal  Streptococcus,  Strain  25,*  witk 
Antistreptococcic  Sera  C13  and  53. 
The mice were inoculated in  the afternoon of the  1st  day  intraperitoneaUy 
with 0.5 cc. each of the sera, and on the morning of the 2nd day with the graduated 
doses of the virulent streptococcus, No. 25, as indicated. 
Mouse  No. 
5 
6 
7 
8 
9 
10 
11 
•  Serum. 
None. 
4# 
0.5 cc. of Serum Sm.C13. 
0.5  "  "  "  "  C13. 
0.5  "  "  "  "  C13. 
0.5  "  "  "  "  C13. 
0.5  "  "  "  "  53. 
0.5  4,  ,,  ,,  "  53. 
0.5  "  "  "  "  53. 
0.5  "  "  "  4,  53. 
Culture. 
cc. 
0.0001 
0.00001 
0.000001 
0.001 
0.0001 
0.00001 
0.000001 
0.001 
0.0001 
0.00001 
0 .O0O0O1 
Result. 
Died in 30 hrs. 
"  "  36  " 
Very  sick  for  2  days,  but 
recovered. 
Died in 36 hrs. 
Survived. 
4~ 
4g 
t~ 
~C 
*Strain 25 had been so raised in virulence through twenty-eight  mouse passages 
that less than 0.00001  cc. of a  blood broth culture killed a  mouse in less than 48 
hours. 
TABLE  X. 
Protection  against  Virulent  Scarlatinal  Streptococcus,  Strain  25,*  wi~  Scarlatinal 
An~streptococcic  Sera,  Nos.  15  an~  76. 
Mouse  No. 
7 
8 
9 
10 
11 
Serum.  Result. 
None. 
4t 
C~ 
0.5 cc. of Serum Sm.15. 
0.5  "  "  "  "  15. 
0.5  ,4  ,  ,,  "  15. 
0.5  "  "  "  "  15. 
0.5  "  4,  ,,  "  76. 
0.5  4,  ,  ,,  "  76. 
0.5  4,  ,4  ,,  "  76. 
0.5  "  "  "  "  76. 
Culture. 
cc, 
0.0001 
0.00001 
0.000001 
0.01 
0.001 
0.0001 
0.00001 
0.01 
0.001 
0.0001 
0.00001 
Died in 72 hrs. 
"  "  36  " 
"  "  24  " 
Survived. 
Died  in  70  hrs. 
fluid sterile.) 
Died in 76 hrs. 
"  "  72  " 
Survived. 
Died in 28 hrs. 
Survived. 
(Peritoneal 
*The strain and the technique used were the same as in Table IX. 598  BIOLOGY  OF  STREPTOCOCCUS.  II 
them.  An  unusual  opportunity  to  study  such  a  set  of  conditions 
was  afforded by  a  localized outbreak of scarlet fever in a  practically 
isolated community? 
Beyond the outskirts of the little village of Claiborn, on the east shore of the 
Chesapeake Bay,  the  Maryland Tuberculosis Association maintains  a  fresh air 
home,  called Claiborn  Cottage,  where  non-tuberculous  children of  tuberculous 
parents, children below par physically, but with no physical signs of tuberculosis, 
are sent for several weeks or months during the summer.  The cottage is situated 
directly on the shore of the bay and is surrounded on the remaining sides by dense 
woods.  No parents or friends visit the cottage.  At the time of the outbreak, 
there were in  the cottage thirty-three children, varying from 3 to 12 years of age, 
and two nurses and four colored helpers.  On September 21,  1920, Wm. W., age 
8, was taken ill with general malaise and a slight sore throat.  He was immediately 
isolated.  Later headache, vomiting, red throat, and flushing of the skin developed. 
On the morning of the 4th day (September 24)  he exhibited a  typical scarlatini- 
form erythema over the face, chest, and body.  He was then transferred  to the 
Sydenham Hospital.  2 days later (September 26) Edw. M., age 4, was taken ill 
with vomiting.  He, too, was promptly quarantined in a  separate room.  2 days 
later he  developed  a  typical angina  and  strawberry tongue.  Simultaneously, 
on September 26,  Jas. L., age  12,  also became ill, and  complained of headache 
and slight sore throat.  He was also quarantined and 2 days later showed a typical 
scarlatinal rash.  Edw. M. and Jas. L. were then sent to Sydenham Hospital, and 
on the day following, Edw. M. exhibited a  scarlatiniform rash.  All three patients 
subsequently experienced typical attacks of  uncomplicated scarlet fever, followed 
by desquamation.  The a~athor visited the three boys at the Sydenham Hospital 
and isolated strains of hemolytic streptococcus from the throats of all.  No other 
case of  scarlet fever developed at  the Claiborn  Cottage. 
The question then arose as to the source of infection.  It could not have been 
the neighboring village, since the children were never allowed to leave the premises 
nor did the villagers ever visit the cottage.  Even the servants lived in a  small 
cottage on the grounds.  Furthermore,  there were  no cases of scarlet fever  re- 
ported in that county at the time.  The milk supply was beyond suspicion, inas- 
much as it came from one small farm nearby, and was handled by only the farmer's 
immediate family and the staff of the Claiborn Cottage.  Careful investigation 
failed to reveal any history of sore throat, or any indisposition whatsoever among 
any of the members of the farmer's family or help.  The infection was not intro- 
duced by visitors since there had been no visitors during the summer.  Suspicion 
was directed, therefore, to the only recent  admissions  to the cottage, three little 
1For this opportunity I  am indebted to Dr.  John  F.  Hogan  of  the  Baltimore 
Department  of Health,  and  to Miss  Spielman  of  the  Maryland  Tuberculosis 
Association. WALTER  PARKS  BLISS  599 
brothers, Joseph, Francis,  and James  B., Russian-Americans,  who had been ad- 
mitted to Claiborn Cottage, September 17, 4 days before the development of the 
first case of scarlet fever.  There had been no other admissions within 3 weeks. 
Joseph, Francis,  and James B., age 11, 10, and 8 years, at the time of observa- 
tion were ap~oarently free from any acute infection, and denied having had sore 
throats recently.  However, at the time they left home,  September 17, a sister, 
Julia B., age  12, was ill with a severe sore throat, which had lasted for several 
days.  She visited on September 20 the children's dispensary of the Johns Hopkins 
Hospital, where it is stated on her record that she had just recovered from an 
acute tonsillitis.  No note was made at that time of the presence of a rash or of 
desquarnation,  nor could a history of these be obtained later from the mother. 
The cottage was visited by the author on October i and cultures were taken on 
blood agar  plates from the  throats of the  thirty-nine inhabitants.  From the 
throats of twenty-three, including  the nurses and helpers,  no hemolytic strepto- 
cocci were recovered.  On the other hand, hemolytic streptococci were obtained 
in greater or less numbers from sixteen of the inmatesof the cottage,  the  largest 
numbers of colonies being present on the plates from James B., Joseph B., and 
Francis B., the three recent admissions.  None of the latter at any time had sore 
throat, fever, or rash.  An immune serum, No. C13, was prepared by immuniza- 
tion of a rabbit with Strain C13 from Joseph B.  The capacity of this serum to 
agglutinate the group of Claiborn streptococci was then tested.  The results of 
this test are shown in Table XI. 
The result of this series of tests demonstrates that none of the strains 
of hemolytic streptococci isolated  from  the  throats  of  the  children 
in  the  Claiborn  Cottage  was  agglutinated  by  the  serum  made  by 
immunization of a  rabbit to one of these  strains  (No.  C13),  except 
the homologous strain,  and  also  (slightly)  Strain  C15  (Francis  B.). 
On the other hand, this serum agglutinated seventeen ot/t ot  twenty 
strains  of  scarlatinal  streptococci  (Table XII).  It  is  of  particular 
interest to note that among these scarlatinal strains were Nos, 76, 77, 
and  78,  the strains isolated from the throats of Win.  W.,  Edw.  M., 
and  Jas.  L.,  the  boys  who  had  contracted  scarlet  fever  while  at 
Claiborn Cottage. 
Furthermore, the Claiborn strains, with the exception of Nos. C13 
and C15, and the irregularly agglutina~ted Strains C9 alad C34, failed 
to  be  agglutinated  by  five  scgrlatinal  antistreptococcic  sera.  The 
results of this test are shown in Table XIII. 
The  series  of  tests  shown  in  Tables  XI  to  XIII  would  seem 
to indicate that hemolytic streptococcus strain, No. C13, carried in the 
throat of Joseph B. differed from all others found in the throats of the 600  BIOLOGY OF  STREPTOCOCCUS.  II 
children at Claiborn, except that from his brother Francis B.,  Strain 
C15.  Study of its agglutination reactions shows it to be of the same 
biological type as strains isolated from the great majority of throats 
in scarlet fever, indicating that it is a true scarlatinal streptococcus. 
TABLE XI. 
Agglutination of Hemolytic Streptococci from tile Throats of Inhabitants  of Claiborn 
Cottage by Serum C13. 
Dilution  of  Antistreptococcic  Serum  C13. 
Streptococcus 
strains. 
C1 
C7 
C8 
C9 
CI0 
C13 
C15 
C18 
C19 
C20 
C21 
C22 
C23 
C30 
C33 
C34 
1:40 
m 
m 
++++ 
++ 
m 
m 
1:80 
M 
m 
u 
++++ 
+ 
m 
M 
I 
m 
1:160 
m 
+++ 
+ 
i 
m 
1:320  . 
++÷ 
N 
B 
u 
1:640 
B 
+++ 
m 
m 
1:1,280 
m 
+++ 
m 
m 
m 
D 
The throats were numbered serially,  as cultured,  so that the above numbers 
represent  the positive  cultures  from the thirty-nine throats examined. 
Immune sera were also made with Strain 76, the strain isolated from Win. W., 
the first case of scarlet fever to develop at Claiborn Cottage.  These sera, Sm.76a, 
and Sm. 76b, agglutinated typically streptococci  isolated  from other  scarlatina] 
throats.  The results  have already been tabulated in Table III.  They also ag- 
glutinated Strain C13 in high dilution,  but failed to agglutinate the other Clai- 
born strains.  In short,  Serum 76 gave identically  the same agglutination reac- 
tions as did Serum  C13. 
A culture was made from the throat of Julia B., the sister of the three boys, and 
although 2 weeks had elapsed  since her  attack  of tonsillitis,  a  few colonies  of WALT]~R PARKS  BLISS  601 
hemolytic streptococcus were obtained.  Strain 79 isolated from this source was 
agglutinated by one antiscarlatinal serum but not by two other such sera.  As the 
strain quickly became persistently granular, this discrepancy could not be further 
investigated. 
A  fourth brother~  Louis B.,  age 9,  came to the  Johns Hopkins  dispensary, 
November 17, giving a history of having had a cold about October 1, just after 
TABLE XIL 
Agglutination  of Scarlatinal  Streptococcus Strains by Serum C13. 
Scarlatlnal  Dilution of Serum C13. 
streptococcus 
strains. 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
88 
89 
90 
91 
93 
94 
95 
98 
99 
1:40  lifO 
++++l++++ 
÷÷÷÷l÷÷÷÷ 
÷÷÷÷  ÷÷÷÷ 
÷÷÷÷  ÷+÷ 
++÷÷  ÷÷÷÷ 
÷÷  ÷÷ 
÷++÷  ÷÷÷÷ 
+÷÷÷  ÷÷÷ 
÷÷÷÷  ÷÷+÷ 
÷÷+÷  ÷+÷÷ 
÷÷+  ++ 
÷+÷  +÷ 
÷+++  +++÷ 
++÷ 
++ 
1:160 
++++ 
++++ 
+++÷ 
+÷ 
++++ 
++ 
÷+++ 
+++÷ 
++++ 
+÷ 
++ 
1:320 
+÷ 
++ 
÷+++ 
++ 
÷+++ 
÷+ 
+++÷ 
÷ 
++ 
++ 
+÷ 
++++ 
++ 
m 
+++÷ 
+ 
++ 
1:640 
+ 
++++ 
++ 
++++ 
++ 
+++ 
+ 
++ 
+++ 
+ 
+++ 
m 
+ 
1:1,280 
++++ 
+ 
++++ 
++ 
+ 
m 
+ 
++ 
+++ 
the sister's recovery from sore throat and while the other three brothers were at 
Claiborn Cottage.  His mother noticed that his face was swollen,  and that during 
the following week the swelling extended to his extremities and abdomen.  The 
patient  had no angina,  rash,  or subsequent  desquamation  of the skin.  About 
October 8, the edema became very marked and he began to have fever and head- 
ache.  He was kept in bed  2 weeks, during which time the swelling gradually 
disappeared.  The mother then noticed urinary frequency, and on November 17, 602  BIOLOGY  OF STILEPTOCOCCUS.  II 
the patient was brought to the Johns Hopkins Hospital dispensary.  At this  time 
his feet were still a little edematous,  and his urine showed a trace of albumin and 
some casts.  His tonsils were enlarged,  and cultures from his throat on a blood 
agar plate yielded a considerable  number of colonies of hemolytic streptococcus. 
The strain isolated is designated  C40.  The agglutination reactions of this strain 
are shown in Table XIV. 
TABLE  XlII. 
Agglutination of Claiborn Contact Streptococcus Strains with Scarlatinal 
Antistreptococcic Sara. 
Claiborn 
contactstrains. 
C1 
C7 
C8 
C9 
CIO 
C13 
C15 
C18 
C19 
C20 
C21 
C22 
C23 
C30 
C33 
C34 
Scarlatinal antistreptococcic sera. 
15a. 
m 
M 
++++++ 
++ 
+++ 
15b. 
+++++ 
+++ 
25. 
+++ 
53a. 
D 
m 
+++ 
+++++ 
++++ 
m 
m 
++++++ 
+++ 
++++ 
u 
m 
m 
m 
+ 
+ 
m 
m 
u 
m 
76a. 
+ 
+++++ 
++++++ 
+++e 
Table XIV shows  Strain  C40 to be closely related to Strain  C13, 
isolated 2 weeks previously from the throat of the patient's brother, 
and to Strain 76, isolated from one of the cases of scarlet fever which 
developed  at  Claiborn  Cottage.  The  failure  of  other  scarlatinal 
antistreptococcic sera tested  to  agglutinate  Strain  C40 is  an irregu- 
larity which cannot be satisfactorily explained at the present time. 
A  second study of contacts was made in connection with a  case of 
scarlet  fever  developing  among  the  women  students  of  the  Johns 
Hopkins  Medical  School.  Immediately  after  the  development  of WALTER  PARKS  BLISS  603 
scarlet fever by the individual mentioned, throat cultures were taken 
of  all  the  women  students  frequenting  the  club  hall  in  which  the 
patient lived, as well as of four men students working in close prox- 
imity  to her in the anatomy dissecting room.  The  throats  of fifty- 
TABLE  XIV. 
Agglutination of Possible Scarlatinal Contact Streptococcus Strain,  No.  C40, with 
Scarlatinal Antistrep~ococeic Sera. 
Sera.  I.  Dilution. 
15a 
15b 
25 
53a 
53b 
76a 
76b 
C13 
I  :20  __ 
++++ 
1:40 
++ 
+++ 
++++ 
1:80 
m 
++ 
+++ 
++++ 
1:160 
m 
++ 
++ 
++++ 
1:320 
++++ 
1:640 
+ 
+ 
++++ 
TABLE  XV. 
Agglutination of a Series of Scarlatinal Contact Streptococcus Strains Mth Scarlatinal 
Antistreptococdc Sera. 
Contact  Scarlatinal  antlstreptococclc  sera, 
streptococcus 
strains.  Sm, 15a.  Sm.25.  Sm.53a.  Sln.?6a. 
D1 
D2 
D3 
D4 
D5 
D6 
D7 
D8 
D9 
D10 
m 
m 
m 
++++++ 
m 
m 
m 
m 
m 
m 
+++ 
N 
m 
m 
++++++ 
three  persons were cultured,  thirty-five  of whom had  been in  close 
contact with  the patient  shortly before she developed scarlet fever. 
Of the total number of throats cultured ten showed hemolytic strepto- 
cocci.  The  results  of  agglutination  tests  of  these  ten  strains  are 
recorded in Table XV. 604  BIOLOGY OF STREPTOCOCCUS. 
From but one individual in the series was a hemolytic streptococcus 
isolated  having  agglutinating properties  similar  to  those  observed 
among streptococci isolated  from scarlet fever.  None of  the  con- 
tacts subsequently developed scarlet fever. 
SUMMARY. 
I.  I-lemolytic streptococcus has been found in |00 per cent of the 
throats  of patients  with  scarlet fever during  the  Ist  week of  the 
disease. 
2.  The average length of time that these organisms are present in 
the throat varies from 10 to 20 days. 
3.  No  morphological  or  cultural  characteristics peculiar  to  the 
hemolytic streptococcus from scarlet fever can be demonstrated. 
4.  Ten immune sera have been prepared from different strains of 
!  . 
scarlet fever streptococci and each of the sera agglutlnated more than 
80 per cent of the strains isolated from scarlatinal throats.  On the 
other hand, scarlatinal streptococd are not agglutinated by immune 
sera prepared from hemolytic streptococci isolated from other patho- 
lo~cal sources. 
5.  Serum from patients  convalescent from scarlet fever aggluti- 
nates  weakly  or  not  at  all  the  homologous  strain  of  hemolytic 
streptococcus. 
6.  The specificity  of the agglutination reaction of scarlatinal strepto- 
cocci is confirmed by absorption experiments. 
7.  Scarlatinal antistreptococdc serum affords some degree of pro- 
tection against virulent scarlet fever streptococci but has no protec- 
tive power against hemolytic streptococci from other diseases. 
8.  In a small epidemic of scarlet fever a healthy carrier of hemolytic 
streptococcus was detected;  the  organism  carried was  identical in 
its serological reactions with strains of hemolytic streptococci isolated 
from active cases of scarlet fever. 
9.  In a study of a number of contacts with a case of scarlet fever, in 
only one instance was a  scarlatinal type of hemolytic streptococcus 
recovered from the throat. WALTER PARKS BLISS  605 
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